02
Jul

Dutch drug developer Kiadis Pharma pulled in €32.7 million ($36.3 million) in a European IPO, raising cash to develop a pair of stem cell treatments.

…read more

Source: Kiadis banks $36M in a Euro IPO to fund its stem cell R&D

    

0 No comments